A Study for Assessing the Safety of Hanita Glaucoma Shunt in Glaucoma Patients

NCT04796883 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-03-02

No results posted yet for this study

Summary

The HANITA Glaucoma Filtration Device is intended to reduce intraocular pressure in glaucoma patients where medical and conventional surgical treatments have failed.

Conditions

Interventions

DEVICE

Hanita Glaucoma shunt Ver.3.2

The procedure will be performed under anesthesia (at physician discretion) and a Hanita shunt devce will be implanted.

Sponsors & Collaborators

  • Hanita Lenses

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2021-11-15
Completion
2021-11-15

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04796883 on ClinicalTrials.gov